NCT04951778
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04951778
Title Study to Evaluate Safety and Tolerability of CC-91633 (BMS-986397) in Participants With Relapsed or Refractory Acute Myeloid Leukemia or Relapsed or Refractory Higher-Risk Myelodysplastic Syndromes
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Celgene
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ESP

Facility Status City State Zip Country Details
Local Institution - 107 Boston Massachusetts 02114 United States Details
Local Institution - 101 Boston Massachusetts 02215 United States Details
Local Institution - 105 St Louis Missouri 63110 United States Details
Local Institution - 104 Houston Texas 77030 United States Details
Local Institution - 109 Seattle Washington 98104 United States Details
Local Institution - 302 Barcelona 08035 Spain Details
Local Institution - 301 Barcelona 08036 Spain Details
Local Institution - 303 Madrid 28041 Spain Details
Local Institution - 304 Seville 41013 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field